{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:08:28Z","timestamp":1794002908067,"version":"4.8.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1053\/j.seminhematol.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T12:31:53Z","timestamp":1573216313000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Platelet transfusion: Alloimmunization and refractoriness"],"prefix":"10.1053","volume":"57","author":[{"given":"Catherine F.","family":"Prodger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-5860","authenticated-orcid":false,"given":"Alexandros","family":"Rampotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-9162","authenticated-orcid":false,"given":"Lise J.","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Stanworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-7503","authenticated-orcid":false,"given":"Michael F.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02961404","article-title":"Ein heizbarer Objecttisch und seine Verwendung bei Untersuchungen des Blutes","volume":"1","author":"Schultze","year":"1865","journal-title":"Archiv f\u00fcr mikroskopische Anatomie"},{"issue":"14","key":"10.1053\/j.seminhematol.2019.10.001_bib0002","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"Description of a method for determining the bleeding and coagulation time and report of three cases of hemorragic disease relieved by transfusion","volume":"55","author":"Duke","year":"1910","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0003","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.me.31.020180.002453","article-title":"Controversies in platelet transfusion therapy","volume":"31","author":"Slichter","year":"1980","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusions in haematology patients: are we using them appropriately?","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sang"},{"issue":"26","key":"10.1053\/j.seminhematol.2019.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2019.10.001_bib0006","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.seminhematol.2019.10.001_bib0007","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"9850","key":"10.1053\/j.seminhematol.2019.10.001_bib0008","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0009","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.14482","article-title":"How do we approach thrombocytopenia in critically ill patients?","volume":"177","author":"Thachil","year":"2017","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0013","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1111\/trf.12214","article-title":"Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets","volume":"53","author":"Johansson","year":"2013","journal-title":"Transfusion"},{"issue":"6","key":"10.1053\/j.seminhematol.2019.10.001_bib0014","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/bjh.15524","article-title":"The use of viscoelastic haemostatic assays in the management of major bleeding: a British Society for Haematology Guideline","volume":"182","author":"Curry","year":"2018","journal-title":"Br J Haematol"},{"issue":"10079","key":"10.1053\/j.seminhematol.2019.10.001_bib0015","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(17)30269-6","article-title":"Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial","volume":"389","author":"Lye","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates","volume":"380","author":"Curley","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0017","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.14233","article-title":"Guidelines on transfusion for fetuses, neonates and older children","volume":"175","author":"New","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2019.10.001_bib0018","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2141.2003.04329.x","article-title":"Bone marrow biopsy morbidity and mortality","volume":"121","author":"Bain","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011771","article-title":"Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia","author":"Estcourt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmrv.2017.05.008","article-title":"Recognition and management of hemostatic disorders in critically ill patients needing to undergo an invasive procedure","volume":"31","author":"Muller","year":"2017","journal-title":"Transfus Med Rev"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0022","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/bja\/aex060","article-title":"Administration of blood products to prevent bleeding complications associated with central venous catheter insertion in patients at risk: a systematic review","volume":"118","author":"Cabrini","year":"2017","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjsurg.2018.06.019","article-title":"Risk of bleeding after ultrasound-guided jugular central venous catheter insertion in severely thrombocytopenic oncologic patients","volume":"217","author":"AlRstum","year":"2019","journal-title":"Am J Surg"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0024","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13063-018-2480-3","article-title":"Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial","volume":"19","author":"van de Weerdt","year":"2018","journal-title":"Trials"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0025","article-title":"Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0026","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"issue":"14","key":"10.1053\/j.seminhematol.2019.10.001_bib0027","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/bloodadvances.2018017699","article-title":"Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial","volume":"2","author":"Cardenas","year":"2018","journal-title":"Blood Adv"},{"issue":"10038","key":"10.1053\/j.seminhematol.2019.10.001_bib0028","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1053\/j.seminhematol.2019.10.001_bib0029","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood.V126.23.772.772","article-title":"Cold-stored platelets in PAS exhibit superior hemostatic potential","volume":"126","author":"Nair","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0030","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/trf.14303","article-title":"Cold platelets for trauma-associated bleeding: regulatory approval, accreditation approval, and practice implementation-just the \"tip of the iceberg\"","volume":"57","author":"Stubbs","year":"2017","journal-title":"Transfusion"},{"issue":"7","key":"10.1053\/j.seminhematol.2019.10.001_bib0031","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197402142900702","article-title":"Hemostatic effectiveness of liquid-preserved and previously frozen human platelets","volume":"290","author":"Valeri","year":"1974","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0032","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/trf.14780","article-title":"Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia","volume":"58","author":"Slichter","year":"2018","journal-title":"Transfusion"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0033","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0049-3848(78)90148-2","article-title":"Preservation of platelet receptors for platelet aggregating factor\/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays","volume":"13","author":"Brinkhous","year":"1978","journal-title":"Thromb Res"},{"issue":"10","key":"10.1053\/j.seminhematol.2019.10.001_bib0034","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2009.03562.x","article-title":"Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine","volume":"7","author":"Hawksworth","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0035","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/trf.14972","article-title":"Safety evaluation of a lyophilized platelet-derived hemostatic product","volume":"58","author":"Barroso","year":"2018","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0036","article-title":"Pathogen-reduced platelets for the prevention of bleeding","volume":"7","author":"Estcourt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0037","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","author":"Crighton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1053\/j.seminhematol.2019.10.001_bib0038","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0039","doi-asserted-by":"crossref","first-page":"h5832","DOI":"10.1136\/bmj.h5832","article-title":"Blood transfusion: summary of NICE guidance","volume":"351","author":"Padhi","year":"2015","journal-title":"BMJ"},{"issue":"10","key":"10.1053\/j.seminhematol.2019.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0041","unstructured":"TRial to EvAluate Tranexamic Acid in Thrombocytopenia."},{"issue":"19","key":"10.1053\/j.seminhematol.2019.10.001_bib0042","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0043","article-title":"Desmopressin use for minimising perioperative blood transfusion","volume":"7","author":"Desborough","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0044","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1538-7836.2008.03269.x","article-title":"Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute","volume":"7","author":"Okamura","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0045","first-page":"337","article-title":"Infusible platelet membrane as a platelet substitute for transfusion: an overview","volume":"11","author":"Nasiri","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0046","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1038\/ncomms11208","article-title":"Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming","volume":"7","author":"Moreau","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0047","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1537-2995.2012.03708.x","article-title":"Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future","volume":"53","author":"Brecher","year":"2013","journal-title":"Transfusion"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0048","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/trf.14202","article-title":"Residual risk of bacterial contamination of platelets: six years of experience with sterility testing","volume":"57","author":"Ramirez-Arcos","year":"2017","journal-title":"Transfusion"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0049","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.transci.2009.10.009","article-title":"Bacterial contamination of platelets","volume":"42","author":"Palavecino","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/voxs.12036","article-title":"Bacterial contamination of blood products","volume":"8","author":"Schmidt","year":"2013","journal-title":"ISBT Science Series"},{"issue":"7","key":"10.1053\/j.seminhematol.2019.10.001_bib0051","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1537-2995.2012.03928.x","article-title":"A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States","volume":"53","author":"Kleinman","year":"2013","journal-title":"Transfusion"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0052","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/trf.14085","article-title":"Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure","volume":"57","author":"McDonald","year":"2017","journal-title":"Transfusion"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0053","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1537-2995.2011.03187.x","article-title":"Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk","volume":"51","author":"Jenkins","year":"2011","journal-title":"Transfusion"},{"issue":"10","key":"10.1053\/j.seminhematol.2019.10.001_bib0054","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/trf.13154","article-title":"Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report","volume":"55","author":"Kou","year":"2015","journal-title":"Transfusion"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12288-013-0236-5","article-title":"A prospective study to determine the frequency of bacterial contamination of platelets","volume":"30","author":"Kulkarni","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0056","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1537-2995.2009.02460.x","article-title":"Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results","volume":"50","author":"Dumont","year":"2010","journal-title":"Transfusion"},{"issue":"6","key":"10.1053\/j.seminhematol.2019.10.001_bib0057","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/trf.13577","article-title":"How do we implement day 6 and day 7 platelets at a hospital-based transfusion service?","volume":"56","author":"Dunbar","year":"2016","journal-title":"Transfusion"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0058","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1537-2995.2008.01799.x","article-title":"The clinical impact of platelet refractoriness: correlation with bleeding and survival","volume":"48","author":"Kerkhoffs","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0059","first-page":"200","article-title":"Relative importance of immune and non-immune causes of platelet refractoriness","volume":"66","author":"Doughty","year":"1994","journal-title":"Vox Sang"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002770050280","article-title":"Frequency and causes of refractoriness in multiply transfused patients","volume":"74","author":"Legler","year":"1997","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2019.10.001_bib0061","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0062","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3148.1993.tb00108.x","article-title":"Formulae for the definition of refractoriness to platelet transfusion","volume":"3","author":"Rebulla","year":"1993","journal-title":"Transfus Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2019.10.001_bib0063","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqy121","article-title":"HLA-mediated platelet refractoriness","volume":"151","author":"Schmidt","year":"2019","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0064","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/voxs.12073","article-title":"Managing the platelet refractory patient","volume":"9","author":"Murphy","year":"2014","journal-title":"ISBT Science Series"},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness\u2014practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2019.10.001_bib0066","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1537-2995.2001.41080984.x","article-title":"Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions","volume":"41","author":"Pappalardo","year":"2001","journal-title":"Transfusion"},{"issue":"26","key":"10.1053\/j.seminhematol.2019.10.001_bib0067","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0068","unstructured":"Group. PB-MEDPeaobotSHoTSS. The 2017 Annual SHOT Report2018."},{"issue":"11","key":"10.1053\/j.seminhematol.2019.10.001_bib0069","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1537-2995.2008.01858.x","article-title":"A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions","volume":"48","author":"Kennedy","year":"2008","journal-title":"Transfusion"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.transci.2017.07.024","article-title":"A national survey of premedication for transfusion reactions in Japan","volume":"56","author":"Fujiwara","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0071","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/trf.13697","article-title":"Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey","volume":"56","author":"Solh","year":"2016","journal-title":"Transfusion"},{"issue":"7","key":"10.1053\/j.seminhematol.2019.10.001_bib0072","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/trf.14126","article-title":"Platelet proteins cause basophil histamine release through an immunoglobulin-dependent mechanism","volume":"57","author":"Lee","year":"2017","journal-title":"Transfusion"},{"issue":"5","key":"10.1053\/j.seminhematol.2019.10.001_bib0073","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/trf.13535","article-title":"Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects","volume":"56","author":"Yasui","year":"2016","journal-title":"Transfusion"},{"issue":"12","key":"10.1053\/j.seminhematol.2019.10.001_bib0074","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1503\/cmaj.141407","article-title":"Peanut and fish allergy due to platelet transfusion in a child","volume":"187","author":"Ching","year":"2015","journal-title":"CMAJ"},{"issue":"20","key":"10.1053\/j.seminhematol.2019.10.001_bib0075","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMc1101692","article-title":"Anaphylaxis from passive transfer of peanut allergen in a blood product","volume":"364","author":"Jacobs","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2019.10.001_bib0076","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1537-2995.2011.03535.x","article-title":"Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly, 2007-2008: utility of large administrative databases in blood safety research","volume":"52","author":"Menis","year":"2012","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0077","unstructured":"NHS Blood and Transplant Annual Report and Accounts 2017\/18. 2018."},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0078","unstructured":"Foundation ABoIM. Choosing Wisely: five things physicians and patients should question. [press release]. 2012."},{"issue":"8","key":"10.1053\/j.seminhematol.2019.10.001_bib0079","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/trf.13075","article-title":"Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients","volume":"55","author":"Butler","year":"2015","journal-title":"Transfusion"},{"issue":"1","key":"10.1053\/j.seminhematol.2019.10.001_bib0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tmrv.2014.10.002","article-title":"The impact of electronic decision support on transfusion practice: a systematic review","volume":"29","author":"Hibbs","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0081","unstructured":"The National Institute for Health and Care Excellence (NICE) (2015) guideline Blood Transfusion (NICE guidance 24). Available athttps:\/\/www.nice.org.uk\/guidance\/ng24\/chapter\/Recommendations-platelets-2(Accessed 29 MAY 2019)."},{"issue":"3","key":"10.1053\/j.seminhematol.2019.10.001_bib0082","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2019.10.001_bib0083","unstructured":"Group OLoEW. The Oxford Levels of Evidence 2. 2009; http:\/\/www.cebm.net."}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196319300642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196319300642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:05Z","timestamp":1758522485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196319300642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0037196319300642"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2019.10.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet transfusion: Alloimmunization and refractoriness","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}